$array = array(
(int) 52 => array(
'News' => array(
'id' => (int) 52,
'published' => '2014-03-03',
'title' => 'Poremećaji u spavanju vode ka dijabetesu i bolestima srca',
'text' => '
<p class="MsoNormal" align="center" style="margin-bottom: 0.0001pt; text-align: center;"><br />
</p>
<p class="MsoNormal" align="center" style="margin-bottom: 0.0001pt; text-align: center;"><i><span style="font-size:14.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:#881A">Kompanija
Philips testiraće do kraja 2018. godine milion ljudi na poremećaje u spavanju,
među kojima je najučestalija opstruktivna apneja</span></i></p>
<p class="MsoNormal" align="center" style="text-align: left; margin-bottom: 0.0001pt;"><span style="font-size: 12pt;">Dobro je poznato da </span><b style="font-size: 12pt;">spavanje</b><span style="font-size: 12pt;">
predstavlja </span><b style="font-size: 12pt;">„treći stub zdravlja"</b><span style="font-size: 12pt;">,
pored pravilne ishrane i vežbanja, i upravo zbog toga je neophodno obratiti
više pažnje na ovaj problem od koga širom sveta pati više od </span><b style="font-size: 12pt;">45%</b><span style="font-size: 12pt;"> populacije. Iako se većina
poremećaja u spavanju može sprečiti i uspešno lečiti, manje od </span><b style="font-size: 12pt;">1/3</b><span style="font-size: 12pt;"> obolelih se obrati lekaru za
stručnu pomoć.</span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> Re</span><span style="font-size: 12pt;">spiratorni poremećaji povezani sa spavanjem, kao i gubitak kvalitetnog
sna, mogu dovesti do brojnih zdravstvenih problema, kao što su </span><b style="font-size: 12pt;">hipertenzija, bolesti srca, moždani udar</b><span style="font-size: 12pt;">
i </span><b style="font-size: 12pt;">dijabetes</b><span style="font-size: 12pt;">.</span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">Nedostatak</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">kvalitetnog</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">sna</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">dovodi</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">do</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">slabije</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">budnosti</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">, </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">smanjenja</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">koncentracije</span><span style="font-size: 12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language: #881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">produktivnosti</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">na</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">poslu</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">pri</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">u</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">č</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">enju</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">, </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">ali</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">i</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">saobra</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">ajnih</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">nesre</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">a</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A">
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A">Povodom<b> Svetskog dana spavanja</b>,
koji se obeležava 14. marta, „Srpsko somnološko društvo" i kompanija Philips
organizovali su konferenciju na temu <b>„Dobar
san za zdrav život</b></span><b><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:#241A">"</span></b><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:#241A">,</span><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:#881A">
28. februara, u hotelu Zira, na kojoj su o važnosti spavanja, kao jednom od glavnih
preduslova za zdrav život, govorili <b>dr
Miodrag Vukčević</b>, načelnik pulmologije KBC „Bežanijska kosa" i <b>prof</b> <b>dr Ludger Grote</b>, iz Univerzitetske bolnice Sahlgenska - Centar za
poremećaje spavanja, Geteburg, Švedska.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-indent: -0.25in;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt; font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol; mso-ansi-language:#881A">·<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><i><span style="font-size:12.0pt;mso-bidi-font-family: Calibri;mso-ansi-language:#881A">Cilj: Do 2018. godine testirati milion ljudi
na poremećaje spavanja
<o:p></o:p></span></i></b></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in;"><b><i><span style="font-size:12.0pt; mso-bidi-font-family:Calibri;mso-ansi-language:#881A"> </span></i></b></p>
<div style="mso-element:para-border-div;border:solid windowtext 1.0pt; mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt">
<p class="MsoNormal" style="margin-bottom: 0.0001pt; border: none; padding: 0in;"><span style="font-size:12.0pt;mso-bidi-font-family: Calibri;mso-ansi-language:#881A">Zbog činjenice da većina osoba koje pate od
opstruktivne apneje u spavanju, kao najčešćeg poremećaja, nema postavljenu
dijagnozu - <b><i>kompanija Philips je sebi postavila za cilj da do kraja 2018. godine
testira milion ljudi širom Severne Amerike, Evrope i Azije</i></b><i>.
<o:p></o:p></i></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; border: none; padding: 0in;"><span style="font-size:12.0pt;mso-bidi-font-family: Calibri;mso-ansi-language:#881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt; border: none; padding: 0in;"><span style="font-size:12.0pt;mso-bidi-font-family: Calibri;mso-ansi-language:#881A">Savetuje se svima da odvoje nekoliko minuta
vremena, a posebno pojedincima koji poseduju neke od simptoma, i urade onlajn
test procene rizika na sajtu „Srpskog somnološkog udruženja" – <b><span style="text-decoration: underline;"><a href="http://www.sss.rs/test.html">www.sss.rs/test.html</a></span></b>. Nakon
završetka testa, svaki učesnik dobiće rezultat na kom nivou rizika od
opstruktivne apneje u spavanja se nalazi, uz preporuku da se obrati lekaru,
ukoliko to rezultat nalaže.
<o:p></o:p></span></p>
</div>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span lang="PL" style="font-size:12.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:PL">„<em><span style="font-family:Calibri;mso-bidi-font-family: Tahoma">Naučno je dokazano da osobe koje pate od poremećaja disanja u spavanju,
ne samo što žive lošije, već žive i od 5 do 10 godina kraće od ostalih</span></em>.
<i>U Srbiji se od poremećaja spavanja leči između 700 i 800 pacijenata, dok se
procenjuje da broj obolelih </i></span><i><span style="font-size:12.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#241A">iznosi oko 350.000</span></i><i><span lang="PL" style="font-size:12.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language: PL">. Upravo to ukazuje na ključni problem - nepostojanje svesti o ovom
problemu. Zato je veoma važno da svako izdvoji nekoliko minuta i
uradi test procene rizika kako bi na vreme počeo sa adekvatnom terapijom
ukoliko se ustanovi poremećaj</span></i><span lang="PL" style="font-size:12.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:PL">." - istakao je <b>dr Miodrag
Vukčević.
<o:p></o:p></b></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><b><span lang="PL" style="font-size:12.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:PL"> </span></b></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Arial;mso-ansi-language: #881A">„<i>Nedostatak sna, vožnja u kasnim
noćnim satima, kao i brojni poremećaji spavanja identifikovani su kao važni
faktori rizika za ozbiljne saobraćajne nesreće. <b>Procenjuje se da je 30% svih smrtnih slučajeva u saobraćajnim nesrećama
povezano sa pospanošću za volanom</b></i><b>.</b>"
– istakao je <b>prof. dr Ludger Grote</b>,
predsednik Skupštine nacionalnih udruženja za san, i<b> </b>pozvao se na podatke prikupljene, u 19 evropskih zemalja, u okviru
projekta „Autobus za buđenje" koje su 2013. godine organizovali Evropsko
udruženje za istraživanje sna i članovi Skupštine nacionalnih udruženja za san.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Arial;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><i><span style="font-size:12.0pt; mso-bidi-font-family:Calibri;mso-ansi-language:#881A">Nesanica, parasomnija</span></i><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:#881A">
(mesečarenje, noćni strahovi, jedenje u snu), <i>REM bihevioralna insomnija, narkolepsija</i> i <i>nedostatak sna</i> - neki su od poremećaja u spavanju, a kao <b>najčešći poremećaj javlja se opstruktivna
apneja, od koje pati oko 5-6% odrasle populacije.
<o:p></o:p></b></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-indent: -0.25in;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt; font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol; mso-ansi-language:#881A">·<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><i><span style="font-size:12.0pt;mso-bidi-font-family: Calibri;mso-ansi-language:#881A">Šta je opstruktivna apneja u spavanju?
<o:p></o:p></span></i></b></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in;"><b><i><span style="font-size: 12pt; text-decoration: underline;"> </span></i></b></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">Ovaj</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">poreme</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">aj</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">karakteri</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">š</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">u</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">prekidi</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">ili</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">pote</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">š</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">ko</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">e</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">u</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">disanju</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">tokom</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">spavanja</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">.
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">Osobama</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">koje</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">pate</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">od</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">opstruktivne</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">apneje</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">disajni</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">putevi</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">su</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">u</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ž</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">od</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">uobi</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">č</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">ajenih</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> - </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">kada</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">se</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">mi</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">š</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> ž</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">drela</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">opuste</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">, </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">nepce</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">pada</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">unazad</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">, š</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">to</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">mo</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ž</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">e</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">dovesti</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">do</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">blokade</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">disajnih</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">puteva</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A">Preveliki jezik, suvišno tkivo i smanjen tonus mišića neki su od faktora
koji prouzrokuju kolaps disajnih puteva. Prestanak disanja može trajati od 10
sekundi do preko minut. Prekidi se mogu javiti od pet do više od sto puta u
toku jednog sata, a pri svakom od njih opada nivo kiseonika. Opstruktivna apneja
u spavanju najčešće se javlja kod muškaraca i gojaznih ljudi, dok pojedinci
koji boluju od ovog poremećaja obično nisu ni svesni da prestaju da dišu u toku
spavanja.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><i><span style="font-size:12.0pt; mso-bidi-font-family:Calibri;mso-ansi-language:#881A">Učestalo glasno hrkanje,
gušenje ili hvatanje vazduha u toku spavanja, preterana pospanost u toku dana,
jutarnje glavobolje, gojaznost, visok krvni pritisak, problemi sa učenjem i
pamćenjem, promene raspoloženja, smanjena koncentracija, osećaj depresije, suvo
grlo posle buđenja i često mokrenje u toku noći</span></i><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:#881A">
– glavni su simptomi opstruktivne apneje u spavanju koji treba da ukažu na
prisustvo problema.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A">Ukoliko se ne leči, ovo oboljenje može povećati rizik od visokog
pritiska, srčanog napada, moždanog udara, preterane gojaznosti i dijabetesa.
Takođe, može povećati i rizik od nepravilnog rada srca, pogoršati srčanu
insuficijenciju, kao i uticati na povećanje rizika od nezgoda na poslu ili pri
vožnji.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><b><span style="font-size:12.0pt; mso-bidi-font-family:Calibri;mso-ansi-language:#881A">Prema podacima Svetske
zdravstvene organizacije, oko 100 miliona ljudi širom sveta pati od
opstruktivne apneje u spavanju, </span></b><span style="font-size:12.0pt; mso-bidi-font-family:Calibri;mso-ansi-language:#881A">dok više od polovine
obolelih nema postavljenu dijagnozu i upravo zato je od velike važnosti da se
osoba, pri uočavanju prvih simptoma, obrati lekaru za stručnu pomoć.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-indent: -0.25in;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt; font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol; mso-ansi-language:#881A">·<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><i><span style="font-size:12.0pt;mso-bidi-font-family: Calibri;mso-ansi-language:#881A">Kako inovacije mogu da pomognu u lečenju
poremećaja u spavanju?
<o:p></o:p></span></i></b></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in;"><b><i><span style="font-size:12.0pt; mso-bidi-font-family:Calibri;mso-ansi-language:#881A"> </span></i></b></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A">Kao kompanija posvećena podizanju svesti u vezi sa poremećajima
spavanja, koji predstavljaju globalnu epidemiju 21. veka, Philips pruža visokokvalitetnu
kućnu zdravstvenu zaštitu za pojedince – od uspostavljanja dijagnoze, praćanje
stanja, do samog lečenja.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A">Zahvaljujući </span><span style="font-size:12.0pt;mso-fareast-font-family: " times="" new="" roman";mso-ansi-language:#881a"="">najsavremenijim inovativnim
rešenjima, Philips je razvio veliki broj proizvoda koji omogućavaju bolji san i
disanje.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language: #881A"> </span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 31.5pt; text-indent: -22.5pt;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings; mso-bidi-font-family:Wingdings;mso-ansi-language:#881A">§<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"="">RUSleeping RTS Screener</span></b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"=""> je efikasan i jednostavan kućni metod za
određivanje apnejskog rezultata pacijenata kojima je potrebna polisomnografija
(PSG), ali zbog prevelikog opterećenja zdravstvenih institucija nisu u
mogućnosti odmah da je zakažu. Lekari koji izdaju upute mogu uz pomoć ovog
uređaja da inicijalno testiraju pacijente na pojave apneje.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 31.5pt; text-indent: -22.5pt;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings; mso-bidi-font-family:Wingdings;mso-ansi-language:#881A">§<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"="">Alice PDx mobilni dijagnostički uređaj</span></b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"=""> za snimanje koristi se kod testiranja
opstruktivne apneje, praćenja i dijagnostičkih procena kardio-respiratornih
poremećaja spavanja</span><span style="font-size:12.0pt;mso-bidi-font-family: Calibri;mso-ansi-language:#881A">. </span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">Ovaj</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">ure</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">đ</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">aj</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">ima</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">napredne</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">funkcije</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">koje</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">odgovaraju</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">savremenim</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">industrijskim</span><span style="font-size: 12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language: #881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma">potrebama</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">,
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">a</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">zbog</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">svoje</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">kompaktne</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">veli</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">č</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">ine</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">pogodan</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">je</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">za</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">ku</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">no</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">testiranje</span><span style="font-size: 12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language: #881A"> - </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma">istovremeno</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">pru</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ž</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">a</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">mogu</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">nost</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">osnovnog</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">testiranja</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">, </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">kao</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">naprednih</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">dijagnosti</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">č</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">kih</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">procena</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">.</span><span style="font-size:12.0pt;mso-bidi-font-family:Calibri;mso-ansi-language:#881A">
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 31.5pt; text-indent: -22.5pt;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings; mso-bidi-font-family:Wingdings;mso-ansi-language:#881A">§<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<span style="font-size:12.0pt;mso-fareast-font-family: " times="" new="" roman";mso-bidi-font-family:arial;mso-ansi-language:#881a"="">Jedna od
glavnih opcija u lečenju opstruktivne apneje u spavanju jesu <b>CPAP aparati</b> (Continuous Positive
Airway Pressure) koji <b>omogućavaju
nesmetano disanje pri spavanju</b>. Terapija omogućava blagi protok vazdušnog
pritiska kroz nos putem maske. </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">Vazdu</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">š</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">ni</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">pritisak</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">spre</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">č</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">ava</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">su</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ž</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">avanje</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">zatvaranje</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">gornjih</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">disajnih</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">puteva</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">, </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">omogu</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">avaju</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">pacijentu</span><span style="font-size: 12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language: #881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma">nesmetano</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">disanje</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">tokom</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">spavanja</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">.
</span><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";="" mso-bidi-font-family:arial;mso-ansi-language:#881a"="">Ova neinvazivna terapija
može da ublaži simptome opstruktivne apnee kada se pravilno koristi. </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 31.5pt; text-indent: -13.5pt;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;font-family:Wingdings;mso-fareast-font-family:Wingdings; mso-bidi-font-family:Wingdings;mso-ansi-language:#881A">§<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"="">BiPAP autoSV Advanced – System One </span></b><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">omogu</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">ava</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">lak</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">š</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">i</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">tretman</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">pacijenata</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">sa</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">apnejom</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">u</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">spavanju</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">koji</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">se</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">susre</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">u</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">sa</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">vi</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">š</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">e</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">
</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family: Tahoma">propratnih</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt; mso-bidi-font-family:Tahoma;mso-ansi-language:#881A"> </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma">poreme</span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">ć</span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma">aja</span><span style="font-size:12.0pt; mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#881A">.
</span><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";="" mso-bidi-font-family:arial;mso-ansi-language:#881a"="">Rešenje pruža lekarima
pravovremene i precizne informacije o pacijentu, što im daje mogućnost da brzo
promene recept ili komuniciraju sa pacijentima, ukoliko je to potrebno. </span><span style="font-size:12.0pt;mso-bidi-font-size:11.0pt;mso-bidi-font-family:Tahoma; mso-ansi-language:#881A">
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 31.5pt; text-indent: -0.25in;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt; font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family: Wingdings;mso-ansi-language:#881A">§<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"="">Amara maska za lice</span></b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"=""> je manja, lakša i manje neprijatna od
tradicionalne maske za celo lice, što je čini jednostavnom za upotrebu i
održavanje i prijatnijom za nošenje. Amara dokazano pristaje licima 95%
pacijenata.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt 31.5pt; text-indent: -0.25in;">
<!--
[if !supportLists]
-->
<span style="font-size:12.0pt; font-family:Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family: Wingdings;mso-ansi-language:#881A">§<span style="font-size: 7pt; font-family: 'Times New Roman';">
</span></span>
<!--
[endif]
-->
<b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"="">Wisp nazalna maska</span></b><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";mso-bidi-font-family:="" arial;mso-ansi-language:#881a"=""> sa minimalnim kontaktom je hibridna
nazalno-jastučna maska, </span><span style="font-size:12.0pt;mso-bidi-font-size: 11.0pt;mso-bidi-font-family:Tahoma;mso-ansi-language:#241A">koja spaja
emocionalni apel i prednosti niskoprofilne maske sa najboljim performansama u
svojoj klasi. </span><span style="font-size:12.0pt;mso-fareast-font-family: " times="" new="" roman";mso-bidi-font-family:arial;mso-ansi-language:#881a"="">Ona pruža
četiri ključne stvari pacijentima: udobnost, jednostavnost upotrebe, vizuelnu
privlačnost i mogućnost pristajanja širokom spektru pacijenata. Modularni okvir
je dostupan u dva stila koja pacijenti mogu da menjaju po želji: tkanina sa dva
lica i providni silikon. To omogućava pacijentima da pre spavanja gledaju
televiziju ili čitaju knjigu, što čitavo iskustvo čini daleko prijatnijim.
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><b><span style="font-size:12.0pt; mso-bidi-font-family:Calibri;mso-ansi-language:#881A">Svetski dan spavanja</span></b><span style="font-size: 12pt;">
(World Sleep Day) obeležava se svake godine, 14. marta, u organizaciji Svetske
asocijacije za medicinu sna, a kompanija Philips, kao lider u inovacijama u
ovoj grani medicine, trudi se da kroz akcije i onlajn testiranje edukuje što
veći broj ljudi o važnosti kvalitetnog sna za zdrav život.</span></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span style="font-size:12.0pt;mso-fareast-font-family:" times="" new="" roman";="" mso-bidi-font-family:calibri;mso-ansi-language:#881a"=""> </span></p> ',
'meta_description' => '',
'meta_keyword' => '',
'meta_title' => '',
'meta' => 'News',
'slug' => 'poremeaji-u-spavanju-vode-ka-dijabetesu-i-bolestima-srca',
'is_active' => true,
'is_deleted' => false,
'modified_by' => (int) 2,
'modified' => '2014-03-03 12:47:15',
'created_by' => (int) 2,
'created' => '2014-03-03 12:46:37'
),
'Image' => array(
'id' => '4571',
'locale' => null,
'association' => 'Image',
'model' => 'News',
'foreign_key' => '52',
'file' => '/upload/News/Image/2014-03/Konferencija_Dobar_San_Za_Zdrav_Zivot.JPG',
'filename' => 'Konferencija_Dobar_San_Za_Zdrav_Zivot',
'path' => '/upload/News/Image/2014-03/',
'filesize' => '214789',
'extension' => 'JPG',
'mimetype' => 'image/jpeg',
'width' => null,
'height' => null,
'is_image' => false,
'extra' => null,
'alt' => null,
'is_deleted' => false,
'meta' => 'a:0:{}',
'ordering' => null,
'modified' => '2014-03-03 12:47:15',
'modified_by' => '2',
'created' => '2014-03-03 12:46:37',
'created_by' => '2'
),
'MetaImage' => array(
'id' => null,
'locale' => null,
'association' => null,
'model' => null,
'foreign_key' => null,
'file' => null,
'filename' => null,
'path' => null,
'filesize' => null,
'extension' => null,
'mimetype' => null,
'width' => null,
'height' => null,
'is_image' => null,
'extra' => null,
'alt' => null,
'is_deleted' => null,
'meta' => null,
'ordering' => null,
'modified' => null,
'modified_by' => null,
'created' => null,
'created_by' => null
),
'Galleries' => array(
(int) 0 => array(
[maximum depth reached]
),
(int) 1 => array(
[maximum depth reached]
),
(int) 2 => array(
[maximum depth reached]
),
(int) 3 => array(
[maximum depth reached]
)
),
'MetaImages' => array()
),
(int) 51 => array(
'News' => array(
'id' => (int) 51,
'published' => '2014-03-03',
'title' => 'NURDOR RODITELJSKA KUĆA – PRVO TRAJNO REŠENJE ZA OBOLELU DECU',
'text' => '
<div>
<p class="MsoNormal" align="center" style="text-align:center;line-height:150%; mso-pagination:widow-orphan;mso-hyphenate:auto;mso-layout-grid-align:none; text-autospace:none"><br />
<div style="text-align: left;"><b style="line-height: 150%; text-align: justify;"><span lang="SR" style="font-size:11.0pt; line-height:150%;font-family:Calibri;mso-fareast-font-family:"Times New Roman"; mso-bidi-font-family:Calibri;mso-fareast-language:SR">Beograd, 27. februar
2014.</span></b><span lang="SR" style="text-align: justify; font-size: 11pt; line-height: 150%; font-family: Calibri;"> – Nacionalno udruženje roditelja dece obolele
od raka NURDOR otvorilo je vrata nove Roditeljske kuće, prve u vlasništvu
Udruženja. Ovim činom trajno je rešen smeštaj mališana i njihovih porodica iz
cele Srbije, koji se leče u Beogradu. Otvaranjem kuće, koja može da primi 8
porodica i nalazi se na Vračaru u Ulici Vukice Mitrović 32, okončani su
petogodišnji napori Udruženja da obezbedi siguran smeštaj porodicama i
realizuje sredstva brojnih donatora koji su pomogli pri ostvarenju cilja.
Visina iznosa prikupljenih donacija, koji je u celosti uložen u kupovinu kuće,
bila je 300.000 evra. Novac je u potpunosti obezbeđen zahvaljujući plemenitosti
brojnih individualnih donatora, institucija i kompanija.</span></div></p>
<p class="MsoNormal" style="text-align: left; line-height: 150%;"><span lang="SR" style="font-size:11.0pt;line-height:150%;font-family:Calibri; mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Calibri; mso-fareast-language:SR"> </span><span style="font-family: Calibri; font-size: 11pt; line-height: 150%;">„Ovo je velik i značajan dan za sve nas, kako mališane
koji se leče, njihove roditelje i ljude dobre volje koji su nas podržali, tako
i nas koji smo učestvovali u projektu. Nakon neuspelih pregovora oko vlasništva
nad Doktorovom kulom, bili smo prinuđeni da odustanemo od njene rekonstrukcije.
Dugo i intenzivno tražili smo rešenje kako bismo olakšali situaciju onima
kojima je pomoć preko potrebna. U dogovoru sa donatorima, sredstva smo usmerili
na kupovinu kuće koja će od danas biti sigurno utočište za mnoge koji se bore i
koji ne odustaju. Ovo je velik dan i za naše društvo koje je pokazalo svoje
plemenito i humano lice. Ponosni na trud koji smo uložili, ističemo da je ovo
peta roditeljska kuća, čija smo vrata zajedno otvorili.", rekao je Todor
Mančić, predsednik UO Udruženja.</span></p>
<p class="MsoNormal" style="text-align: left; line-height: 150%;"><span lang="SR" style="font-size:11.0pt;line-height:150%;font-family:Calibri; mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Calibri; mso-fareast-language:SR"> </span><span style="font-family: Calibri; font-size: 11pt;">Nova kuća, kupljena u
odličnom stanju, nalazi se u mirnom okruženju, u blizini klinika i ispunjava
sve potrebne uslove. Na površini od 250 kvadratnih metara smešteno je 7
porodičnih soba, dva dnevna boravka, dve kuhinje, četiri kupatila i terasa sa
malim dvorištem. Objekat je u potpunosti opremljen i spreman da primi prve stanare.</span></p></div>',
'meta_description' => '',
'meta_keyword' => '',
'meta_title' => '',
'meta' => 'News',
'slug' => 'nurdor-roditeljska-kua--prvo-trajno-reenje-za-obolelu-decu',
'is_active' => true,
'is_deleted' => false,
'modified_by' => (int) 2,
'modified' => '2014-03-03 12:42:26',
'created_by' => (int) 2,
'created' => '2014-03-03 12:42:26'
),
'Image' => array(
'id' => '4568',
'locale' => null,
'association' => 'Image',
'model' => 'News',
'foreign_key' => '51',
'file' => '/upload/News/Image/2014-03/NURDOR_Malo_Znaci_Mnogo.jpg',
'filename' => 'NURDOR_Malo_Znaci_Mnogo',
'path' => '/upload/News/Image/2014-03/',
'filesize' => '416226',
'extension' => 'jpg',
'mimetype' => 'image/jpeg',
'width' => null,
'height' => null,
'is_image' => false,
'extra' => null,
'alt' => null,
'is_deleted' => false,
'meta' => 'a:0:{}',
'ordering' => null,
'modified' => '2014-03-03 12:42:26',
'modified_by' => '2',
'created' => '2014-03-03 12:42:26',
'created_by' => '2'
),
'MetaImage' => array(
'id' => null,
'locale' => null,
'association' => null,
'model' => null,
'foreign_key' => null,
'file' => null,
'filename' => null,
'path' => null,
'filesize' => null,
'extension' => null,
'mimetype' => null,
'width' => null,
'height' => null,
'is_image' => null,
'extra' => null,
'alt' => null,
'is_deleted' => null,
'meta' => null,
'ordering' => null,
'modified' => null,
'modified_by' => null,
'created' => null,
'created_by' => null
),
'Galleries' => array(
(int) 0 => array(
[maximum depth reached]
),
(int) 1 => array(
[maximum depth reached]
)
),
'MetaImages' => array()
),
(int) 50 => array(
'News' => array(
'id' => (int) 50,
'published' => '2014-02-18',
'title' => 'KOMBINOVANI HORMONSKI KONTRACEPTIVI - Izvor:alims.gov.rs',
'text' => '
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR; mso-bidi-font-weight:bold">Februar 2014.
<o:p></o:p></span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR; mso-bidi-font-weight:bold"> </span></p>
<p class="Default" align="center" style="text-align:center"><b><span lang="SR" style="font-size:11.0pt;mso-ansi-language:SR">PITANJA I ODGOVORI O KOMBINOVANIM
HORMONSKIM KONTRACEPTIVIMA: INFORMACIJE ZA PACIJENTKINJE -
<o:p></o:p></span></b><b style="text-align: justify;"><span lang="SR" style="font-size: 10pt;">nove informacije</span></b></p>
<p class="Default" align="center" style="text-align:center"><b><span lang="SR" style="font-size:11.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 11.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Zašto su nove informacije
sada postale dostupne? </span></b><span lang="SR" style="font-size:10.0pt; mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Nedavno je na nivou Evrope sprovedena sveobuhvatna
procena odnosa koristi i rizika primene kombinovanih hormonskih kontraceptiva,
s posebnim osvrtom na rizik nastanka krvnih ugrušaka koji je povezan s primenom
ovih lekova.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Svrha ovog dokumenta je da pruži više informacija
o riziku nastanka krvnih ugrušaka, uključujući informacije o stanjima koja
povećavaju rizik od ugruška, informacije o znakovima i simptomima krvnog
ugruška i informacije o tome kada je potrebno reći lekaru ili farmaceutu da
koristite ove lekove.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">S obzirom na to da se nedavna procena odnosa
koristi i rizika kombinovanih hormonskih kontraceptiva odnosila upravo na rizik
nastanka krvnih ugrušaka, u ovom dokumentu navodi se niz informacija upravo o
tom riziku. Međutim, važno je zapamtiti da su kombinovani hormonski
kontraceptivi vrlo efikasni lekovi za sprečavanje neželjene trudnoće, a da je
ukupni rizik od krvnih ugrušaka nizak. Za većinu žena, korist primene ovih
lekova daleko nadmašuje nizak rizik od ozbiljnih neželjenih reakcija.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Ove informacije se ne odnose na lekove koji sadrže
samo progestagen, a ne sadrže etinilestradiol ili estradiol.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Koji su zaključci i
preporuke sprovedene procene? </span></b><span lang="SR" style="font-size:10.0pt; mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Rizik od krvnih ugrušaka povezan sa primenom kombinovanih
hormonskih kontraceptiva poznat je već dugi niz godina. Nedavna procena potvrdila
je prethodno saznanje o tome da je rizik nizak, a sada je naglasak na tome da
se pruže korisne informacije o ovom riziku.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Ako bez ikakvih tegoba koristite svoj kombinovani
hormonski kontraceptiv, na osnovu rezultata pomenute procene nema potrebe da
prestanete sa njegovom primenom. U slučaju zabrinutosti, prilikom sledećeg
rutinskog pregleda obratite se lekaru koji je propisao lek, ali u međuvremenu
nastavite sa primenom leka. Potrebno je zapamtiti da iznenadan prestanak
uzimanja kombinovanog hormonskog kontraceptiva može imati za posledicu
neplaniranu trudnoću.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Šta su kombinovani
hormonski kontraceptivi? </span></b><span lang="SR" style="font-size:10.0pt; mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Kombinovani hormonski kontraceptivi su vrlo
efikasni lekovi za sprečavanje neplanirane trudnoće. Sadrže dva hormona:
estrogen i progestagen. Većina sadrži estrogen koji se naziva etinilestradiol,
ali neki kombinovani hormonski kontraceptivi sadrže drugi estrogen koji se
naziva estradiol. Dostupan je veliki broj progestagena.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;background:lime;mso-highlight:lime;mso-ansi-language:SR">
<o:p> </o:p></span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Koje su koristi uzimanja
kombinovanih hormonskih kontraceptiva? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Osim sprečavanja neplanirane trudnoće, kombinovani
hormonski kontraceptivi imaju i druge dugoročne korisne efekte, kao što su
smanjenje rizika od raka endometrijuma (unutrašnjeg sloja materice) i raka
jajnika.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Ostali mogući korisni efekti njihove primene su poboljšanje
kontrole menstrualnog ciklusa, simptoma endometrioze (poremećaj unutrašnjeg
sloja materice), upalnih bolesti karlice i, kod nekih žena, akni. U samo
nekoliko studija upoređivani su korisni efekti različitih kombinovanih
hormonskih kontraceptiva međusobno, i stoga nije jasno postoje li ikakve
značajne razlike između njih u tom pogledu.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Za većinu žena, ovi lekovi nose koristi koje
daleko nadmašuju nizak rizik od pojave ozbiljnih neželjenih reakcija.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Koji su rizici primene
kombinovanih hormonskih kontraceptiva? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Kao i svi lekovi, kombinovani hormonski
kontraceptivi su povezani sa nekim rizicima. Najčešći rizici uključuju nelagodnost
u dojkama, promene raspoloženja i promene telesne mase. Velike studije su takođe
otkrile i vrlo malo povećanje rizika od raka dojke i raka grlića materice.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Verovatno najvažniji rizik
povezan sa primenom ovih lekova jeste nastanak krvnih ugrušaka.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;background:lime;mso-highlight:lime;mso-ansi-language:SR">
<o:p> </o:p></span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Što se može dogoditi ako
imam krvni ugrušak? </span></b><span lang="SR" style="font-size:10.0pt; mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Krvni ugrušci obično nastaju u nogama (što se
naziva dubokom venskom trombozom), ali u nekim slučajevima se mogu otkinuti i
dospeti u krvne sudove pluća (što se naziva plućna embolija). Krvni ugrušci
takođe mogu nastati u krvnim sudovima srca, uzrokujući srčani udar, ili u
krvnim sudovima mozga, uzrokujući moždani udar. Dakle krvni ugrušci mogu biti
vrlo ozbiljna neželjena reakcija, i u vrlo retkim slučajevima mogu dovesti do
smrtnog ishoda.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;background:lime;mso-highlight:lime;mso-ansi-language:SR">
<o:p> </o:p></span></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Koliko je visok rizik od krvnih ugrušaka pri
primeni kombinovanih hormonskih kontraceptiva? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Svi kombinovani hormonski kontraceptivi blago
povećavaju rizik od krvnih ugrušaka, međutim, važno je imati na umu da je ovaj
rizik nizak.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Rizik nastanka krvnih ugrušaka pri primeni kombinovanih
hormonskih kontraceptiva je najveći tokom prve godine korištenja - ovo se
odnosi na pacijentkinje koje nikada ranije nisu koristile ove lekove, kao i na
pacijentkinje koje su imale pauzu u uzimanju ovih lekova u trajanju od 4 nedelje
ili duže. Rizik od nastanka krvnog ugruška je veći i kod onih pacijentkinja
koje prirodno imaju viši rizik (videti deo „<i>Koji
drugi faktori mogu povećati rizik od krvnih ugrušaka?</i>").
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Rizik nastanka krvnih ugruška pri primeni kombinovanih
hormonskih kontraceptiva opada nakon prve godine korištenja, ali ostaje viši od
rizika koji imaju žene koje ne koriste ove lekove. Rizik se vraća na normalne
vrednosti nekoliko meseci nakon prestanka uzimanja ovih lekova.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;background:lime;mso-highlight:lime;mso-ansi-language:SR">
<o:p> </o:p></span></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Da li je rizik od krvnih ugrušaka jednak sa svim
kombinovanim hormonskim kontraceptivima? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Velike studije sprovedene tokom niza godina
pružile su dobre dokaze da rizik od krvnih ugrušaka može varirati između
različitih kombinovanih hormonskih kontraceptiva. Smatra se da razlika zavisi od
doze estrogena i vrste progestagena koju ovi lekovi sadrže. Važno je zapamtiti
da je ukupni rizik od krvnih ugrušaka povezan s primenom bilo kojeg od ovih lekova
nizak za većinu žena.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Kombinovani hormonski kontraceptivi koji sadrže
etinilestradiol i jedan od sledećih progestagena: levonorgestrel, norgestimat
ili noretisteron, imaju rizik koji je <span style="text-decoration: underline;">manji</span> u poređenju sa kombinovanim hormonskim kontraceptivima
koji sadrže druge progestagene.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Koliko žena će imati
krvni ugrušak?
<o:p></o:p></span></b></p>
<p class="Default" style="text-align:justify;mso-outline-level:1"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Smatra se da:
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- <span style="text-decoration: underline;">Otprilike 2</span> od 10 000 zdravih žena koje <span style="text-decoration: underline;">ne
koriste</span> kombinovane hormonske kontraceptive će u godini dana imati krvni
ugrušak.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="margin-right:-9.0pt;text-align:justify"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">- <span style="text-decoration: underline;">Otprilike 5 do 7</span> od 10
000 zdravih žena koje koriste kombinovane hormonske kontraceptive koji sadrže
etinilestradiol i levonorgestrel, norgestimat ili noretisteron će u godini dana
imati krvni ugrušak.
<o:p></o:p></span></p>
<p class="Default" style="margin-right:-9.0pt;text-align:justify"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="margin-right:-9.0pt;text-align:justify"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">- <span style="text-decoration: underline;">Otprilike 9 do 12</span> od 10
000 zdravih žena koje koriste kombinovane hormonske kontraceptive koji sadrže
etinilestradiol i gestoden, dezogestrel ili drospirenon će u godini dana imati
krvni ugrušak.
<o:p></o:p></span></p>
<p class="Default" style="margin-right:-9.0pt;text-align:justify"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="margin-right:-9.0pt;text-align:justify"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">- <span style="text-decoration: underline;">Otprilike 6 do 12</span> od 10
000 zdravih žena koje koriste kombinovane hormonske kontraceptive koji sadrže
etinilestradiol i etonogestrel ili norelgestromin će u godini dana imati krvni
ugrušak.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- <span style="text-decoration: underline;">Broj žena kod kojih može nastati krvni
ugrušak još nije poznat za neke kombinovane hormonske kontraceptive</span>. Ovo
uključuje sledeće kombinacije: etinilestradiol i dienogest, etinilestradiol i
hlormadinon, estradiol i dienogest, estradiol i nomegestrol.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="margin-left:.25pt;border-collapse:collapse;mso-table-layout-alt:fixed; border:none;mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:480; mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-insideh:.5pt solid windowtext; mso-border-insidev:.5pt solid windowtext">
<tbody>
<tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:17.5pt">
<td width="307" style="width: 230.15pt; border: 1pt solid windowtext; padding: 0in 5.4pt; height: 17.5pt;">
<p class="Default" align="center" style="text-align:center"><b><span lang="SR" style="font-size:10.0pt;color:windowtext;mso-ansi-language: SR">Scenario<span style="background:lime;mso-highlight:lime">
<o:p></o:p></span></span></b></p>
</td>
<td width="284" style="width: 212.9pt; border-style: solid solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-bottom-color: windowtext; border-top-width: 1pt; border-right-width: 1pt; border-bottom-width: 1pt; padding: 0in 5.4pt; height: 17.5pt;">
<p class="Default" align="center" style="text-align:center"><b><span lang="SR" style="font-size:10.0pt;color:windowtext;mso-ansi-language: SR">Rizik nastanka krvnog ugruška u godini dana<span style="background:lime; mso-highlight:lime">
<o:p></o:p></span></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow:1;height:7.1pt">
<td width="307" style="width: 230.15pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt; height: 7.1pt;">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Žena ne koristi kombinovani hormonski kontraceptiv (tableta,
transdermalni flaster ili intravaginalni prsten) i nije trudna
<o:p></o:p></span></p>
</td>
<td width="284" valign="top" style="width:212.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:7.1pt">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Otprilike 2 slučaja na 10 000 zdravih žena<span style="background:lime; mso-highlight:lime">
<o:p></o:p></span></span></p>
</td>
</tr>
<tr style="mso-yfti-irow:2;height:7.1pt">
<td width="307" style="width: 230.15pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt; height: 7.1pt;">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Žena koristi kombinovani hormonski kontraceptiv koji sadrži <span style="text-decoration: underline;">etinilestradiol</span>
i levonorgestrel, norgestimat ili noretisteron
<o:p></o:p></span></p>
</td>
<td width="284" valign="top" style="width:212.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:7.1pt">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Otprilike 5 do 7 slučajeva na 10 000 zdravih žena<span style="background: lime;mso-highlight:lime">
<o:p></o:p></span></span></p>
</td>
</tr>
<tr style="mso-yfti-irow:3;height:7.1pt">
<td width="307" style="width: 230.15pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt; height: 7.1pt;">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Žena koristi kombinovani hormonski kontraceptiv koji sadrži <span style="text-decoration: underline;">etinilestradiol</span>
i gestoden, dezogestrel ili drospirenon
<o:p></o:p></span></p>
</td>
<td width="284" valign="top" style="width:212.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:7.1pt">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Otprilike 9 do 12 slučajeva na 10 000 zdravih žena
<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow:4;height:7.1pt">
<td width="307" style="width: 230.15pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt; height: 7.1pt;">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Žena koristi kombinovani hormonski kontraceptiv koji sadrži <span style="text-decoration: underline;">etinilestradiol</span>
i etonogestrel ili norelgestromin
<o:p></o:p></span></p>
</td>
<td width="284" valign="top" style="width:212.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:7.1pt">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Otprilike 6 do 12 slučajeva na 10 000 zdravih žena
<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow:5;mso-yfti-lastrow:yes;height:7.1pt">
<td width="307" style="width: 230.15pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt; height: 7.1pt;">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Žena koristi kombinovani hormonski kontraceptiv koji sadrži neku od
sledećih kombinacija: <span style="text-decoration: underline;">etinilestradiol i dienogest</span>,<span style="text-decoration: underline;"> etinilestradiol
i hlormadinon</span>, <span style="text-decoration: underline;">estradiol i dienogest, estradiol i nomegestrol
<o:p></o:p></span></span></p>
</td>
<td width="284" valign="top" style="width:212.9pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:7.1pt">
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">Još nije poznat broj žena kod kojih se može javiti krvni ugrušak
<o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Koji drugi faktori mogu povećati rizik od krvnih
ugrušaka? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">
<o:p></o:p></span></p>
<p class="Default" style="margin-right:-5.4pt;text-align:justify"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Rizik od krvnih ugrušaka
razlikuje se između pojedinih osoba i bez korištenja kombinovanih hormonskih
kontraceptiva. Brojni faktori povećavaju rizik od krvnih ugrušaka, pa će rizik
prirodno biti viši ako:
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- ste stariji od 35 godina,
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- ste gojazni,
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- imate brata, sestru ili roditelja koji je imao
krvni ugrušak u relativno mladoj dobi (npr. mlađoj od 50 godina),
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- imate zdravstveno stanje koje povećava rizik od
krvnih ugrušaka, kao što je rak.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Kod žena koje <span style="text-decoration: underline;">puše</span>, rizik od pojave krvnih
ugrušaka koji uzrokuju srčani i moždani udar je povećan, pogotovo ako su
starije od 35 godina.
<o:p></o:p></span></p>
<p class="Default" style="margin-right:30.6pt;text-align:justify"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Kod žena koje nemaju nijedan od gorenavedenih
faktora, rizik od nastanka krvnih ugrušaka tokom primene kombinovanih
hormonskih kontraceptiva je izuzetno nizak.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Kod žena koje imaju nekoliko gorenavedenih
faktora, rizik od nastanka krvnih ugrušaka tokom primene kombinovanih
hormonskih kontraceptiva je viši. U nekim slučajevima, prisutnost nekoliko
faktora rizika može značiti da ne bi trebalo koristiti kombinovane hormonske
kontraceptive i da je potrebno sa lekarom razmotriti druge oblike
kontracepcije.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Važno je zapamtiti da se vaš prirodni rizik nastanka
krvnih ugrušaka menja tokom vremena, na primer u slučaju značajnog porasta
telesne mase, početka ili povećanog konzumiranja cigareta i nakon velikih
operacija, o čemu je važno obavestiti lekara koji vam je propisao kombinovani
hormonski kontraceptiv.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Na šta je potrebno obratiti pažnju? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Važno je obratiti pažnju na simptome pojave krvnog
ugruška, naročito ako ste:
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- nedavno imali operaciju,
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">- mirovali duže vreme (npr. zbog povrede ili
bolesti) ili bili na dugom putovanju (npr. dugolinijski letovi).
<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Odmah
potražite medicinsku pomoć ukoliko imate neki od sledećih simptoma:
<o:p></o:p></span></b></p>
<p class="MsoNormal"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt; mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-insideh: .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext">
<tbody>
<tr>
<td width="295" valign="top" style="width: 221.4pt; border: 1pt solid windowtext; padding: 0in 5.4pt;">
<p class="Default"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></b></p>
<p class="Default" align="center" style="text-align:center"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Imate li bilo koji od ovih
znakova?</span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR">
<o:p></o:p></span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
</td>
<td width="295" valign="top" style="width: 221.4pt; border-style: solid solid solid none; border-top-color: windowtext; border-right-color: windowtext; border-bottom-color: windowtext; border-top-width: 1pt; border-right-width: 1pt; border-bottom-width: 1pt; padding: 0in 5.4pt;">
<p class="Default"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></b></p>
<p class="Default" align="center" style="text-align:center"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Na šta ukazuju ovi znakovi?</span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default"><span lang="SR" style="font-size:10.0pt;mso-ansi-language: SR"> </span></p>
</td>
</tr>
<tr>
<td width="295" valign="top" style="width: 221.4pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt;">
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Jak bol ili oticanje noge koje može pratiti
osetljivost, osećaj toplote ili promena boje kože, kao što su bledilo,
crvenilo ili plava boja kože
<o:p></o:p></span></p>
</td>
<td width="295" valign="top" style="width:221.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt">
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Duboka venska tromboza
<o:p></o:p></span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
</td>
</tr>
<tr>
<td width="295" valign="top" style="width: 221.4pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt;">
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Iznenadan neobjašnjivi gubitak daha ili ubrzano
disanje; jak bol u grudima koji se pogoršava pri dubokom disanju; iznenadni
kašalj bez očiglednog razloga (koji može da dovede do iskašljavanja krvi)
<o:p></o:p></span></p>
</td>
<td width="295" valign="top" style="width:221.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt">
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Plućna embolija
<o:p></o:p></span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
</td>
</tr>
<tr>
<td width="295" valign="top" style="width: 221.4pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt;">
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Bol, nelagodnost, pritisak ili težina u grudima,
nelagodnost u gornjem delu tela koja se širi na leđa, vilicu, grlo ili ruku,
praćena osećajem punoće u želucu, probavnih smetnji ili gušenja; znojenje,
mučnina, povraćanje ili vrtoglavica
<o:p></o:p></span></p>
</td>
<td width="295" valign="top" style="width:221.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt">
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Srčani udar
<o:p></o:p></span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
</td>
</tr>
<tr>
<td width="295" valign="top" style="width: 221.4pt; border-style: none solid solid; border-right-color: windowtext; border-bottom-color: windowtext; border-left-color: windowtext; border-right-width: 1pt; border-bottom-width: 1pt; border-left-width: 1pt; padding: 0in 5.4pt;">
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Slabost ili utrnulost lica, ruke ili noge, naročito
na jednoj strani tela, teškoće u govoru ili razumevanju govora, iznenadna zbunjenost,
iznenadan gubitak vida ili zamagljen vid, jaka glavobolja ili migrena koja je
teža od uobičajene
<o:p></o:p></span></p>
</td>
<td width="295" valign="top" style="width:221.4pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt; mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt">
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Moždani udar
<o:p></o:p></span></p>
<p class="Default" align="center" style="text-align:center"><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Šta očekivati na lekarskom pregledu? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Potrebno je da sa lekarom koji vam je propisao
kombinovani hormonski kontraceptiv porazgovarate o koristima i rizicima primene
ovih lekova. Lekar će naglasiti nizak rizik od krvnih ugrušaka koji nose ovi lekovi,
stanja koja povećavaju rizik od krvnih ugrušaka i proći će kroz neke od
ključnih znakova i simptoma kojih pacijentkinje treba da budu svesne.
<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Šta je potrebno da uradite ako uzimate kombinovani
hormonski kontraceptiv? </span></b><span lang="SR" style="font-size:10.0pt; mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Ako bez ikakvih tegoba koristite svoj kombinovani
hormonski kontraceptiv, na osnovu rezultata sprovede procene nema potrebe da
prestanete s njegovom primenom. U slučaju zabrinutosti, prilikom sledećeg
rutinskog pregleda obratite se lekaru koji je propisao lek, ali u međuvremenu
nastavite sa primenom leka.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Potrebno je zapamtiti da iznenadan prestanak
uzimanja kombinovanog hormonskog kontraceptiva može imati za posledicu
neplaniranu trudnoću. Rizik od nastanka krvnih ugrušaka tokom trudnoće i
neposredno nakon porođaja je veći od rizika povezanog sa primenom ovih lekova.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Važno je da svakom lekaru koji vas leči (na primer
ako idete na operaciju) kažete da uzimate kombinovani hormonski kontraceptiv.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="Default" style="text-align:justify"><b><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Gde pronaći više informacija? </span></b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR">Ako koristite kombinovani hormonski kontraceptiv potrebno
je da <b>pažljivo pročitate</b> <b>uputstvo za lek</b> priloženo u pakovanju
leka, kako biste bili svesni rizika od krvnih ugrušaka, upoznati sa znakovima i
simptomima krvnih ugrušaka (odnosno duboke venske tromboze, plućne embolije,
srčanog udara ili moždanog udara), kao i da znate šta je potrebno uraditi ako
imate bilo šta od navedenog.
<o:p></o:p></span></p>
<p class="Default" style="text-align:justify"><span lang="SR" style="font-size: 10.0pt;mso-ansi-language:SR"> </span></p>
<p class="MsoNormal" style="text-align:justify"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR"> </span></b></p>
<p class="MsoNormal" style="text-align:justify"><b><span lang="SR" style="font-size:10.0pt;mso-ansi-language:SR">Za dodatne
informacije potrebno je obratiti se lekaru koji je propisao lek.
<o:p></o:p></span></b></p> ',
'meta_description' => '',
'meta_keyword' => '',
'meta_title' => '',
'meta' => 'News',
'slug' => 'kombinovani-hormonski-kontraceptivi-izvoralimsgovrs',
'is_active' => true,
'is_deleted' => false,
'modified_by' => (int) 2,
'modified' => '2014-02-18 15:03:59',
'created_by' => (int) 2,
'created' => '2014-02-18 15:03:32'
),
'Image' => array(
'id' => '4564',
'locale' => null,
'association' => 'Image',
'model' => 'News',
'foreign_key' => '50',
'file' => '/upload/News/Image/2014-02/Shutterstock_97872497.jpg',
'filename' => 'Shutterstock_97872497',
'path' => '/upload/News/Image/2014-02/',
'filesize' => '2288888',
'extension' => 'jpg',
'mimetype' => 'image/jpeg',
'width' => null,
'height' => null,
'is_image' => false,
'extra' => null,
'alt' => null,
'is_deleted' => false,
'meta' => 'a:0:{}',
'ordering' => null,
'modified' => '2014-02-18 15:03:59',
'modified_by' => '2',
'created' => '2014-02-18 15:03:32',
'created_by' => '2'
),
'MetaImage' => array(
'id' => null,
'locale' => null,
'association' => null,
'model' => null,
'foreign_key' => null,
'file' => null,
'filename' => null,
'path' => null,
'filesize' => null,
'extension' => null,
'mimetype' => null,
'width' => null,
'height' => null,
'is_image' => null,
'extra' => null,
'alt' => null,
'is_deleted' => null,
'meta' => null,
'ordering' => null,
'modified' => null,
'modified_by' => null,
'created' => null,
'created_by' => null
),
'Galleries' => array(),
'MetaImages' => array()
),
(int) 48 => array(
'News' => array(
'id' => (int) 48,
'published' => '2014-02-03',
'title' => 'Srbija protiv raka',
'text' => '
<div><br />
</div>
<div>Nacionalnim programom ranog otkrivanja karcinoma grlića materice, dojke i debelog creva obuhvaćeno je 20 odsto građana ciljne grupe i postignuti su planirani rezultati, saopštilo je Ministarstvo zdravlja.</div>
<div>Ministarstvo zdravlja objavilo je javni poziv za prijavu projekata za realizaciju Nacionalnog programa "Srbija protiv raka" i u ovoj godini planira se je povećanje broja domova zdravlja u kojima će se sprovoditi Nacionalni program skrininga .Projekte mogu prijaviti bolnice i klinički centri iz plana mreže zdravstvenih ustanova, a prijavu projekta mogu zajednički podneti dve ili više zdravstvenih ustanova.</div>
<div>U prvoj godini sprovođenja skrininga raka dojke obuhvaćeno je 20 odsto žena od 50 do 69 godina, preventivni pregledi se sprovode u 27 domova zdravlja , a u ovoj godini pregledi će se sprovoditi u 41 domu zdravlja.</div>
<div>Skrining raka grlića materice sprovodi se u 12 domova zdravlja i pozivaju se žene od 25 do 64 godine. Pozivom je obuhvaćeno 48 odsto žena ciljne grupe (87.875), od kojih se odazvalo 47,9 odsto, a prema planu za ovu godinu skrining će se sprovoditi u 42 doma zdravlja.</div>
<div>Žene i muškarci od 50 do 74 godine pozivaju se na skrining karcinoma debelog creva i preventivni pregledi sprovodi se u 20 domova zdravlja.</div>
<div>Pozivom je obuhvaćeno 14,7odsto građana (36.862), od kojih se odazvalo 61,4 odsto pozvanih iz ciljne grupe, a u ovoj godini pregledi će se sprovoditi u 31 domu zdravlja.</div>
<div>Ministarstvo zdravlja je u saradnji sa mrežom instituta i zavoda za javno zdravlje i zdravstvenih ustanova, u decembru 2012. godine započelo je sprovođenje organizovanih skrining programa raka dojke, raka grlića materice i raka debelog creva.</div>
<div><br />
</div>
<div>Izvor: Tanjug</div> ',
'meta_description' => '',
'meta_keyword' => '',
'meta_title' => '',
'meta' => 'News',
'slug' => 'srbija-protiv-raka',
'is_active' => true,
'is_deleted' => false,
'modified_by' => (int) 2,
'modified' => '2014-02-11 11:21:10',
'created_by' => (int) 2,
'created' => '2014-02-03 10:00:07'
),
'Image' => array(
'id' => '4476',
'locale' => null,
'association' => 'Image',
'model' => 'News',
'foreign_key' => '48',
'file' => '/upload/News/Image/2014-02/Rak1.jpg',
'filename' => 'Rak1',
'path' => '/upload/News/Image/2014-02/',
'filesize' => '32962',
'extension' => 'jpg',
'mimetype' => 'image/jpeg',
'width' => null,
'height' => null,
'is_image' => false,
'extra' => null,
'alt' => null,
'is_deleted' => false,
'meta' => 'a:0:{}',
'ordering' => null,
'modified' => '2014-02-11 11:21:10',
'modified_by' => '2',
'created' => '2014-02-03 10:00:07',
'created_by' => '2'
),
'MetaImage' => array(
'id' => null,
'locale' => null,
'association' => null,
'model' => null,
'foreign_key' => null,
'file' => null,
'filename' => null,
'path' => null,
'filesize' => null,
'extension' => null,
'mimetype' => null,
'width' => null,
'height' => null,
'is_image' => null,
'extra' => null,
'alt' => null,
'is_deleted' => null,
'meta' => null,
'ordering' => null,
'modified' => null,
'modified_by' => null,
'created' => null,
'created_by' => null
),
'Galleries' => array(),
'MetaImages' => array()
)
)
$sort = 'News.published'
$result = array()
manualSort - ROOT/VectorCMS/Config/functions.conf.php, line 142
DefaultBehavior::afterFind() - ROOT/VectorCMS/Model/Behavior/DefaultBehavior.php, line 204
ObjectCollection::trigger() - CORE/Cake/Utility/ObjectCollection.php, line 128
call_user_func - [internal], line ??
CakeEventManager::dispatch() - CORE/Cake/Event/CakeEventManager.php, line 243
Model::_filterResults() - CORE/Cake/Model/Model.php, line 3352
Model::_readDataSource() - CORE/Cake/Model/Model.php, line 3042
AppModel::find() - ROOT/VectorCMS/Model/AppModel.php, line 1834
PaginatorComponent::paginate() - CORE/Cake/Controller/Component/PaginatorComponent.php, line 196
Controller::paginate() - CORE/Cake/Controller/Controller.php, line 1087
FrontController::beforeFilter() - ROOT/VectorCMS/Controller/FrontController.php, line 163
call_user_func - [internal], line ??
CakeEventManager::dispatch() - CORE/Cake/Event/CakeEventManager.php, line 243
Controller::startupProcess() - CORE/Cake/Controller/Controller.php, line 677
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 189
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - ROOT/VectorCMS/webroot/index.php, line 146
Warning (2): Invalid argument supplied for foreach() [ROOT/VectorCMS/Config/functions.conf.php, line 142]
manualSort - ROOT/VectorCMS/Config/functions.conf.php, line 142
DefaultBehavior::afterFind() - ROOT/VectorCMS/Model/Behavior/DefaultBehavior.php, line 204
ObjectCollection::trigger() - CORE/Cake/Utility/ObjectCollection.php, line 128
call_user_func - [internal], line ??
CakeEventManager::dispatch() - CORE/Cake/Event/CakeEventManager.php, line 243
Model::_filterResults() - CORE/Cake/Model/Model.php, line 3352
Model::_readDataSource() - CORE/Cake/Model/Model.php, line 3042
AppModel::find() - ROOT/VectorCMS/Model/AppModel.php, line 1834
PaginatorComponent::paginate() - CORE/Cake/Controller/Component/PaginatorComponent.php, line 212
Controller::paginate() - CORE/Cake/Controller/Controller.php, line 1087
FrontController::beforeFilter() - ROOT/VectorCMS/Controller/FrontController.php, line 163
call_user_func - [internal], line ??
CakeEventManager::dispatch() - CORE/Cake/Event/CakeEventManager.php, line 243
Controller::startupProcess() - CORE/Cake/Controller/Controller.php, line 677
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 189
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - ROOT/VectorCMS/webroot/index.php, line 146
Warning (2): Cannot modify header information - headers already sent by (output started at /home/bbsoft/public_html/bbsoft.rs/lib/Cake/Utility/Debugger.php:800) [CORE/Cake/Network/CakeResponse.php, line 449]
setcookie - [internal], line ??
CakeResponse::_setCookies() - CORE/Cake/Network/CakeResponse.php, line 449
CakeResponse::send() - CORE/Cake/Network/CakeResponse.php, line 419
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 174
[main] - ROOT/VectorCMS/webroot/index.php, line 146
Kompanija
Philips testiraće do kraja 2018. godine milion ljudi na poremećaje u spavanju,
među kojima je najučestalija opstruktivna apneja
Dobro je poznato da spavanje
predstavlja „treći stub zdravlja",
pored pravilne ishrane i vežbanja, i upravo zbog toga je neophodno obratiti
više pažnje na ova...
Beograd, 27. februar
2014. – Nacionalno udruženje roditelja dece obolele
od raka NURDOR otvorilo je vrata nove Roditeljske kuće, prve u vlasništvu
Udruženja. Ovim činom trajno je rešen smeštaj mališana i njihovih porodica iz
cele Srbije, koji se leče u Beogradu. Otvaranjem kuće, koja može da prim...
Februar 2014.
PITANJA I ODGOVORI O KOMBINOVANIM
HORMONSKIM KONTRACEPTIVIMA: INFORMACIJE ZA PACIJENTKINJE - nove informacije
Zašto su nove informacije
sada postale dostupne?
Nedavno je na nivou Evrope sprovedena sveobuhvatna
procena odnosa koristi i rizika primene kombinovanih hormonsk...
Nacionalnim programom ranog otkrivanja karcinoma grlića materice, dojke i debelog creva obuhvaćeno je 20 odsto građana ciljne grupe i postignuti su planirani rezultati, saopštilo je Ministarstvo zdravlja. Ministarstvo zdravlja objavilo je javni poziv za prijavu projekata za realizaciju Nacionaln...
Molimo sačekajte...